# Inhibition of PTTG1 suppresses proliferation and promotes differentiation of neuroblastoma cells by inducing autophagy

**Authors:** Lihua Yuan, Xiaobo Wang, Kanglin Dai, Kenneth Kak Yuen Wong

PMC · DOI: 10.1007/s00383-025-06246-w · Pediatric Surgery International · 2025-11-20

## TL;DR

This study shows that inhibiting PTTG1 in neuroblastoma cells reduces their growth and increases autophagy, promoting cell differentiation.

## Contribution

The novel finding is that PTTG1 inhibition promotes autophagy and differentiation in neuroblastoma cells.

## Key findings

- PTTG1 inhibition reduces proliferation, invasion, and migration in SK-N-SH cells.
- PTTG1 interference increases autophagy markers like LC3II and beclin1.
- Autophagy inhibition with 3-MA reverses the effects of PTTG1 suppression.

## Abstract

PTTG1 is an oncogene that is highly expressed in various cancers and is involved in regulating the cell cycle in neuroblastoma (NB) cells. However, the specific role of PTTG1 in NB has not been extensively reported. We undertook this study to investigate the expression of PTTG1 in various NB cell lines to identify the gene expression patterns.

Small interfering RNA (siRNA) targeting PTTG1 was designed and used to transfect NB cells. Cell proliferation levels, wound healing and transwell experiments were undertaken to assess the invasion and migration abilities of transfected and control NB cells. Western blot, PCR, and immunofluorescence experiments were utilized to detect the expression of migration-related proteins, differentiation-related proteins, and autophagy-related proteins in NB cells. Different doses of the autophagy inhibitor 3-methyladenine (3-MA) were used for validating the mechanism.

High expression of PTTG1 was seen in three types of NB cell lines, with the most significant levels observed in SK-N-SH cells. Interference of PTTG1 significantly inhibited the activity of SK-N-SH cells, reducing their proliferation, invasion, and migration abilities, and was accompanied by a decrease in MMP2 and MMP9 protein expression. In addition, there was enhancement of fluorescence intensity of the differentiation marker TUBB3 and the autophagy marker LC3II, and upregulated the protein expression and mRNA levels of GAP43, TH, MEG, TUBB3, LC3II/LC3I, and beclin1, while downregulated the expression levels of P62 and mTOR. After applying the autophagy inhibitor 3-MA, the regulation of SK-N-SH cell proliferation and differentiation by PTTG1 interference was significantly reduced.

PTTG1 is highly expressed in various NB cells. Interfering with PTTG1 induces autophagy, thereby inhibiting SK-N-SH cell proliferation and promoting differentiation.

## Linked entities

- **Genes:** PTTG1 (PTTG1 regulator of sister chromatid separation, securin) [NCBI Gene 9232], MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318], GAP43 (growth associated protein 43) [NCBI Gene 2596], TH (tyrosine hydroxylase) [NCBI Gene 7054], PTPN4 (protein tyrosine phosphatase non-receptor type 4) [NCBI Gene 5775], TUBB3 (tubulin beta 3 class III) [NCBI Gene 10381], Map1lc3a (microtubule-associated protein 1 light chain 3 alpha) [NCBI Gene 362245], Map1lc3a (microtubule-associated protein 1 light chain 3 alpha) [NCBI Gene 362245], BECN1 (beclin 1) [NCBI Gene 8678], GTF2H1 (general transcription factor IIH subunit 1) [NCBI Gene 2965], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475]
- **Proteins:** MMP2 (matrix metallopeptidase 2), MMP9 (matrix metallopeptidase 9), GAP43 (growth associated protein 43), TH (tyrosine hydroxylase), PTPN4 (protein tyrosine phosphatase non-receptor type 4), TUBB3 (tubulin beta 3 class III), Map1lc3a (microtubule-associated protein 1 light chain 3 alpha), Map1lc3a (microtubule-associated protein 1 light chain 3 alpha), BECN1 (beclin 1), GTF2H1 (general transcription factor IIH subunit 1), MTOR (mechanistic target of rapamycin kinase)
- **Chemicals:** 3-methyladenine (PubChem CID 135398661), 3-MA (PubChem CID 135398661)
- **Diseases:** neuroblastoma (MONDO:0005072)

## Full-text entities

- **Genes:** TUBB3 (tubulin beta 3 class III) [NCBI Gene 10381] {aka CDCBM, CDCBM1, CFEOM3, CFEOM3A, FEOM3, TUBB4}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, GAP43 (growth associated protein 43) [NCBI Gene 2596] {aka B-50, GAP-43, PP46}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, PTPN4 (protein tyrosine phosphatase non-receptor type 4) [NCBI Gene 5775] {aka MEG, PTPMEG, PTPMEG1}, PTTG1 (PTTG1 regulator of sister chromatid separation, securin) [NCBI Gene 9232] {aka EAP1, ECRAR, HPTTG, PTTG, TUTR1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, NUP62 (nucleoporin 62) [NCBI Gene 23636] {aka IBSN, SNDI, p62}
- **Diseases:** NB (MESH:D009447), cancers (MESH:D009369)
- **Chemicals:** 3-MA (MESH:C025946)
- **Cell lines:** SK-N-SH — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0531)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12634700/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12634700/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12634700/full.md

---
Source: https://tomesphere.com/paper/PMC12634700